Hindustan Copper shares continue their bullish run with a 4% surge, riding the wave of copper prices that have skyrocketed more than 50% in less than 60 days. Discover what's driving this unprecedented rally and expert outlook.
Discover the incredible journey of Waaree Renewables, the small-cap stock that delivered massive 400% returns and continues its winning streak with recent 20% surge. Is this renewable energy player still a buy?
Discover how one affordable small-cap stock is bucking the bearish trend with impressive gains while most stocks tumble. Find out what's driving this unexpected rally.
Mazagon Dock Shipbuilders delivers impressive Q2 FY24 performance with 53% profit surge and 9% revenue growth. Expert analysis reveals whether this defence PSU stock is a buy or sell opportunity.
Get expert stock market insights from ICICI Securities' Dharmesh Shah as he reveals why Axis Bank and Kansai Nerolac present compelling buying opportunities with detailed technical analysis and target prices.
Expert Sumeet Bagadia reveals three budget-friendly stocks under ₹100 with strong growth potential. Discover these hidden gems for your Monday trading strategy and learn why they're poised for significant gains.
Discover why international markets from Europe to Japan are outperforming the S&P 500, and what this global rally means for Indian investors seeking diversification beyond US stocks.
Discover why prominent investor Mukul Agrawal is betting big on a small-cap pharma company with massive growth potential. Get exclusive insights into his latest portfolio move and what it means for retail investors.
Looking for affordable investment opportunities? Mehul Kothari of Anand Rathi shares three promising stocks trading under ₹100 with strong growth potential in this exclusive market analysis.
Discover how Dr. Anji Reddy's visionary journey from generics to innovative drug research positioned India as a global pharmaceutical powerhouse and continues to inspire future generations.
In a revolutionary healthcare development, Bangladesh's Beximco Pharma launches affordable generic version of lifesaving rare disease drug, dramatically reducing treatment costs from crores to lakhs for patients across South Asia.
Sigachi Industries faces turbulent quarter with net profit crashing to ₹10.5 crore amid significant revenue decline. What's behind the pharmaceutical giant's disappointing performance?
Cipla's stock faces unexpected pressure despite securing rights to manufacture and distribute Eli Lilly's revolutionary weight loss drug Mounjaro in India. Discover why investors remain cautious.
Indian pharmaceutical giant Cipla announces landmark deal with Eli Lilly to manufacture and distribute popular weight loss medications Mounjaro and Zepbound in India under different brand names.
Three major European aerospace companies join forces to create revolutionary satellite internet network, aiming to compete with SpaceX's Starlink in global connectivity race.
Indian pharma giant Aurobindo Pharma establishes new subsidiary in Chile, marking strategic expansion across South American markets with focus on branded prescriptions and over-the-counter medicines.
Discover how a little-known small-cap stock under ₹50 stunned investors with a massive 20% surge following a crucial business development. Find out what triggered this explosive rally and whether the momentum can continue.
In a major pharmaceutical industry move, Torrent Pharmaceuticals receives Competition Commission of India approval to acquire controlling stake in JB Chemicals & Pharmaceuticals, marking significant consolidation in Indian pharma sector.
A significant legal triumph for India's pharmaceutical sector strengthens the position of generic drug makers against patent challenges. Explore how this ruling impacts affordable medicine production and India's role as the 'Pharmacy of the World'.
Danish pharma giant Novo Nordisk, the company behind diabetes & weight-loss blockbusters Ozempic and Wegovy, announces a major boardroom reshuffle. Get the inside scoop on the new faces and strategic direction.
Meet the trailblazing female entrepreneurs who built healthcare empires from scratch and are reshaping medical innovation worldwide. Discover their inspiring journeys to billions.
Delhi Police uncovers how Nigerian drug cartels are recruiting Indian students from pharma colleges, providing specialized training, and creating sophisticated dispatch systems to smuggle narcotics globally.
Expert analysis compares Zydus Lifesciences and Rubicon Research in the booming Indian pharmaceutical sector. Discover key financial metrics, growth drivers, and investment outlook for these promising stocks.
India's pharmaceutical sector gears up for Q2 FY25 with projected 5-7% revenue growth, navigating US pricing pressures and domestic GST reductions while maintaining stable profitability.
Discover the incredible Diwali stock picks that delivered 100x returns last year. Learn which 10 companies turned modest investments into massive wealth and what experts say about spotting future multibaggers.
English golfer Tommy Fleetwood triumphs at DP World India Championship 2025 in Gurugram, celebrating victory with emotional embrace from his son Frankie. Relive the touching father-son moment that stole hearts.
In a major breakthrough, Narcotics Control Bureau uncovers sophisticated drug manufacturing unit in Madhya Pradesh's Ratlam district. Highly educated pharma graduates among those arrested in interstate narcotics operation.
India mandates safety QR codes on all essential medicines in public healthcare, transforming drug safety and combating counterfeit drugs with digital innovation.
Madhya Pradesh's Special Investigation Team gears up for significant arrests in the Sresan Pharma cough syrup case that claimed young lives. Exclusive details on the expanding investigation.
In a landmark judgment, India's Supreme Court allows Natco Pharma to produce affordable generic version of Roche's expensive spinal muscular atrophy treatment, making life-saving therapy accessible to thousands.